DIA472.21+4.92 1.05%
SPX6,791.69+53.25 0.79%
IXIC23,204.87+263.07 1.15%

12 Health Care Stocks Moving In Friday's Pre-Market Session

Benzinga·10/17/2025 12:13:10
Listen to the news

Gainers

  • Rani Therapeutics Hldgs (NASDAQ:RANI) stock rose 152.7% to $1.19 during Friday's pre-market session. The company's market cap stands at $22.5 million.
  • Artiva Biotherapeutics (NASDAQ:ARTV) shares moved upwards by 107.94% to $5.76. The market value of their outstanding shares is at $67.4 million.
  • XORTX Therapeutics (NASDAQ:XRTX) shares rose 50.58% to $1.28. The market value of their outstanding shares is at $4.4 million.
  • Kezar Life Sciences (NASDAQ:KZR) shares rose 37.88% to $5.75. The market value of their outstanding shares is at $30.5 million.
  • Akanda (NASDAQ:AKAN) stock rose 23.31% to $2.75. The market value of their outstanding shares is at $1.6 million.
  • Disc Medicine (NASDAQ:IRON) shares rose 21.03% to $90.0. The market value of their outstanding shares is at $2.5 billion.

Losers

  • Sensei Biotherapeutics (NASDAQ:SNSE) stock declined by 46.3% to $9.44 during Friday's pre-market session. The market value of their outstanding shares is at $22.1 million.
  • INVO Fertility (NASDAQ:IVF) shares decreased by 28.58% to $1.0. The market value of their outstanding shares is at $6.1 million.
  • AVITA Medical (NASDAQ:RCEL) stock fell 25.85% to $3.99. The company's market cap stands at $145.3 million.
  • NewGenIvf Group (NASDAQ:NIVF) stock fell 25.53% to $1.51. The market value of their outstanding shares is at $4.3 million.
  • Protalix BioTherapeutics (AMEX:PLX) stock declined by 19.17% to $1.94. The market value of their outstanding shares is at $191.3 million.
  • rYojbaba (NASDAQ:RYOJ) shares declined by 14.5% to $4.07. The market value of their outstanding shares is at $53.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2025 Webull Securities Limited. All rights reserved.